Table 1.
Basic characteristics of patients whose blood sample were collected for the analysis of serum HGF in Fig. 7a
| CTEPH group |
PTE survivors (Control group) |
p value | |
|---|---|---|---|
| Number of patients | 61 | 12 | |
| Age (y) | 62.1 ± 10.6 | 71.0 ± 12.4 | < 0.01 |
| Sex (M:F) | 14:47 | 0:12 | n.s. |
| Systolic blood pressure (mmHg) | 121.9 ± 21.5 | 135.4 ± 10.8 | < 0.05 |
| Diastolic blood pressure (mmHg) | 73.9 ± 14.3 | 71.2 ± 10.0 | n.s. |
| Total cholesterol (mg/dl) | 192.6 ± 33.8 | 197.5 ± 24.9 | n.s. |
| ALT (U/l) | 25.9 ± 10.2 | 24.5 ± 6.1 | n.s |
| AST (U/l) | 20.5 ± 11.7 | 19.9 ± 6.93 | n.s. |
| ɤ-GTP (U/l) | 48.6 ± 49.9 | 39.5 ± 49.8 | n.s. |
| C-Reactive Protein (mg/dl) | 0.18 ± 0.33 | 0.11 ± 0.16 | n.s. |
| BNP (pg/ml) | 147.2 ± 264.5 | 40.1 ± 34.4 | n.s. |
| Disease duration (month)a | 32.1 ± 36.6 | 89.4 ± 42.6 | < 0.01 |
| Mean Pulmonary artery pressure (mmHg) | 41.8 ± 10.3 | – | – |
| Pulmonary artery resistance (dyne.sec.cm− 5) | 661.6 ± 287.7 | – | – |
| Cardiac Index (L/min/m2) | 2.74 ± 0.68 | – | – |
| NYHA(I:II:III:IV) | 0:42:18:1 | – | – |
Data are presented as either mean ± SD or actual value
aTime from the onset of symptom to the blood sampling